Navigation Links
Overcoming Taboos, Myths, and Dogmas in Bioethics
Date:12/15/2008

Few areas of public policy have been fraught with as much controversy as bioethics. Although some people dispute whether it is even a discipline, bioethics tackles some of the most complex and sensitive issues confronting modern society. From discussions on abortion to assisted dying, bioethicists are there.

Each novel development in biomedical technology seems to spark rancorous disputes. FUTURE BIOETHICS: OVERCOMING TABOOS, MYTHS, AND DOGMAS (Prometheus Books, $29.98) is an ambitious book that seeks to reframe the debates surrounding current controversies in bioethics. Not only does it explore laws and policies behind bioethics technologies, it also takes a deep look into the personal decisions and ideas of ordinary people.

"Lindsay's discussion of contemporary bioethical issues is distinguished by features that are sorely needed in serious books for the popular audience: clarity without condescension, and depth without obscurantism," says Barbara Forrest, coauthor with Paul R. Gross of Creationism's Trojan Horse: The Wedge of Intelligent Design, "His arguments are informed by common sense, compassion, and respect for ordinary people who must make the life-altering decisions that have become routine not only in modern medical care but in virtually all aspects of life in the modern world."

Those averse to new technologies often express the concern that the new technology is "unnatural" or requires us to "play God." Slogans such as "Frankenfoods" and "sanctity of life" substitute for reasoned argument. For some reason, these phrases became so frequently used that they replaced most facts about the subject.

Bioethicist Ronald A. Lindsay seeks to expose and debunk these myths. As Nature points out, "He does so in a book that is readable rather than obscure, and accessible to the interested lay person as well as to scholars in the field. Reckoning that progress is unlikely unless we can identify some common moral
'/>"/>

Contact: Lynn Pasquale
publicitydepartment@prometheusbooks.com
800-853-7545
Prometheus Books
Source:Eurekalert  

Page: 1 2

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Overcoming Taboos, Myths, and Dogmas in Bioethics
(Date:8/4/2015)... , Aug. 04, 2015 ... http://www.researchandmarkets.com/research/nvh7k2/digital_forensics ) has announced the addition of ... (Hardware, Software, and Service), Sub-Segment (Computer Forensics, ... Forensics), Tool Types, Service, Vertical and Region ... to their offering. By Component ...
(Date:7/31/2015)... , Kina, 31. juli 2015 Den ... bliver afholdt af BGI fra den 22. - 25. oktober ... Konferencen fejrer sin 10-års fødselsdag i år. Siden ... mest indflydelsesrige årlige møder på ,omik,-feltet, og er en ... ICG-10 fokuserer på nylige gennembrud og ...
(Date:7/31/2015)... 31 juillet 2015 La 10e Conférence ... sera organisée par le BGI du 22 au ... en Chine. La conférence célèbre ... en 2006, l,ICG est devenue l,une des réunions ... des « omiques » et c,est aussi la plus dynamique, ...
Breaking Biology News(10 mins):Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3
... may be associated with more advanced physical disability and ... by neurologists at the University at Buffalo have shown. ... Neurology meeting, held earlier this month, indicated that:, ... insufficient vitamin D levels. , Clinical evaluation and ...
... N.Y. Changing the hue of hospital gowns and bed ... a physician,s ability to detect cyanosis and other health-related skin ... Institute. "If a doctor sees a patient, and then ... or no idea whether the patient,s skin has changed color," ...
... Forget what you know about how diseases are diagnosednew ... FASEB Journal ( http://www.fasebj.org ) details a noninvasive ... stages before symptoms can be seen using traditional methods. Even ... early that they may be reversed before any permanent damage ...
Cached Biology News:Low vitamin D levels are related to ms brain atrophy, cognitive function, studies show 2Nude-colored hospital gowns could help doctors better detect hard-to-see symptoms 2New tool helps scientists 'see' molecular signals of eye disease before symptoms arise 2
(Date:8/28/2015)... ... August 28, 2015 , ... ... presented two studies at the International Spine Intervention Society’ s 23rd ... through to August 1st, 2015. With a focus on evidence-based research and clinical ...
(Date:8/28/2015)... ... , ... Since the initial launch of FireflySci Inc. (FFS) in early 2015, the company continues ... Images such as the Fonz in a lab coat and Large Marge have been posted ... field. , FireflySci is proud to be the only cuvette manufacturer is the ...
(Date:8/27/2015)... /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC Market: ... Holding Company Limited (Biohaven), announced today that dosing ... BHV-0223, a glutamate modulating agent. Biohaven filed an ... obtained clearance from the U.S. Food and Drug ... holds 54% equity interest in Biohaven, a private ...
(Date:8/27/2015)... Aug. 27, 2015 HUYA Bioscience International (HUYA) today ... the Japan Society of HTLV-1, held this week at ... purpose of the Society is to promote research on ... of medical technology and research related to these fields ... "HUYA is proud to support this prestigious conference," ...
Breaking Biology Technology:Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 2Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 3Proove Biosciences Presents New Research Study at the International Spine Intervention Society’s Annual Scientific Meeting 4Cuvette Manufacturer FireflySci Launches Back to School Deals with Complimentary Shipping On All Orders 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 2HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 3HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 4
... that it intends to release the results of its ... approximately 4:00 p.m. Eastern,Time (ET). Following the release, at ... discuss the results of its first quarter of fiscal ... one hour in,duration. The conference call will also be ...
... JobLoft.com, a leading online job,board that lists ... on,geographic proximity, announced today the expansion of ... acquisition of RegionalHelpWanted.com by,its parent company, onTargetjobs. ... 350 geographically focused,Internet job boards, JobLoft.com now ...
... - Company Establishes U.S. subsidiary in Philadelphia Area ... a leader in in,vivo cellular imaging, announced today ... Inc. is the U.S. subsidiary of Paris-based Mauna,Kea ... new,endoscopic imaging approach which improves patient care by ...
Cached Biology Technology:Martek to Announce First Quarter 2008 Results on March 5, 2008 2JobLoft.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition 2Chris Tihansky Appointed President of In Vivo Cellular Imaging Leader Cellvizio Inc. 2